Adverum Biotechnologies Profit Margin 2013-2021 | ADVM
Current and historical gross margin, operating margin and net profit margin for Adverum Biotechnologies (ADVM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Adverum Biotechnologies net profit margin as of June 30, 2021 is 0%.
|Adverum Biotechnologies Annual Profit Margins
|Adverum Biotechnologies Quarterly Profit Margins
||Medical - Biomedical and Genetics
Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum?s core capabilities include clinical development, novel vector discovery and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control.